Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition (Q28212407)

Europe PubMed Central

title

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition (English)

0 references

6

Ravi Salgia

0 references

author name string

Gautam Maulik

1

0 references

Amol Shrikhande

2

0 references

Takashi Kijima

3

0 references

Patrick C Ma

4

0 references

Paul T Morrison

Cytokine and Growth Factor Reviews

5

0 references

language of work or name

English

0 references

publication date

February 2002

0 references

published in

0 references

volume

13

0 references

page(s)

41-59

0 references

issue

1

0 references

cites work

Molecular cloning of a new transforming gene from a chemically transformed human cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Mechanism of met oncogene activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Activating mutations for the met tyrosine kinase receptor in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Chicken macrophage stimulating protein is a ligand of the receptor protein-tyrosine kinase Sea.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Plexins, semaphorins, and scatter factor receptors: a common root for cell guidance signals?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Signalling by semaphorin receptors: cell guidance and beyond.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The HGF receptor family: unconventional signal transducers for invasive cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Organization of the human hepatocyte growth factor-encoding gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The mutationally activated Met receptor mediates motility and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Infrequent mutations of the MET gene in sporadic breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Clinical significance of c-met oncogene alterations in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Aberrant expression of c-met mRNA in human gastric carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

A novel germ line juxtamembrane Met mutation in human gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Missense mutation of the MET gene detected in human glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Expression of the c-met protooncogene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The clinical significance of hepatocyte growth factor for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Overexpression of the Met/HGF receptor in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

c-met proto-oncogene expression in benign and malignant human prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Independent prognostic value of serum hepatocyte growth factor in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

HGF: a multifunctional growth factor controlling cell scattering.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The molecular basis of lung morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Down-regulation of MET, the receptor for hepatocyte growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Actin-based cell motility and cell locomotion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Role of focal adhesion proteins in signal transduction and oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Involvement of focal adhesion kinase in hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Growth factor regulation of integrin-mediated cell motility

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Differential signaling by the focal adhesion kinase and cell adhesion kinase beta

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Rho GTPases control polarity, protrusion, and adhesion during cell movement

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Involvement of the adapter protein CRKL in integrin-mediated adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Essential role of Gab1 for signaling by the c-Met receptor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3-kinase and phospholipase C.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2801%2900029-6

7 January 2021

10.1016/S1359-6101(01)00029-6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3772941

3772941

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference